An innovative model for pharmacogenomics critical results identification and intervention
- PMID: 41038816
- DOI: 10.1038/s41397-025-00385-y
An innovative model for pharmacogenomics critical results identification and intervention
Abstract
Pharmacogenomics (PGx) test results are returned variably across healthcare settings, which can lead to challenges particularly when results require immediate intervention to avoid adverse consequences. While several return of result models exist in literature, a standard-of-care has not been established. We propose a model to safely return PGx results in the context of scaled and sustained PGx testing: an institutional protocol to integrate new PGx results into patient care.
© 2025. The Author(s), under exclusive licence to Springer Nature Limited.
Conflict of interest statement
Competing interests: The authors declare no competing interests.
References
-
- Thorn CF, Klein TE, Altman RB. PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base. Methods Mol Biol (Clifton, N.J.). 2005;311:179–91.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
